CureVac and GSK Collaboration and License Agreement

• Post author:GHIAA Editor
• Post published:September 15, 2021
• Post category:

Continue ReadingCureVac and GSK Collaboration and License Agreement

Novavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement

• Post author:GHIAA Admin
• Post published:September 10, 2021
• Post category:

Continue ReadingNovavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement

NIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

• Post author:GHIAA Admin
• Post published:June 30, 2021
• Post category:

Continue ReadingNIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

Sanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement

• Post author:GHIAA Admin
• Post published:December 14, 2020
• Post category:

Continue ReadingSanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement

Merck – Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingMerck – Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement

Gilead – Indian Generic Manufacturers, HCV License Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingGilead – Indian Generic Manufacturers, HCV License Agreement

NIH – Non-Profit, Model License Agreement Terms

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingNIH – Non-Profit, Model License Agreement Terms

MPP – Pfizer, Sutezolid License Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingMPP – Pfizer, Sutezolid License Agreement

MPP – ViiV, Dolutegravir License Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingMPP – ViiV, Dolutegravir License Agreement